CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets 14:30:36 10/08/2026 BST			5-day change	1st Jan Change
0.000100 ^USD	0.00%		0.00%	+9,900.00%

09/09/21	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
03/09/21	CardioGenics Holdings Inc. Announces License Agreement	CI

Market Cap	382K 330K 310K 282K 530K 36.54M 539K 3.63M 1.42M 18.3M 1.43M 1.4M 60.81M	P/E 2014	-2.3x	P/E 2015	-2.17x
Enterprise Value	539K 465K 437K 398K 748K 51.51M 760K 5.12M 2M 25.79M 2.02M 1.98M 85.72M	EV / Sales 2014	-	EV / Sales 2015	-
Free-Float	97.49%	Yield 2014 *	-	Yield 2015	-

09/09/21	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
03/09/21	CardioGenics Holdings Inc. Announces License Agreement	CI
01/11/15	CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	CI
04/10/15	CardioGenics Holdings Inc entered into a non-binding letter of intent to acquire substantially all of the assets of Plasticap Inc.	CI
12/01/15	CardioGenics Holdings Inc. Appoints Karim Murabet as Director	CI
27/09/13	CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013	CI
21/08/13	CardioGenics Holdings Inc Announces Commencement of Beta-Site Testing	CI
05/06/13	CardioGenics Holdings Inc Announces Internal Review Board Approval for Beta-Site Testing	CI
03/06/13	CardioGenics Holdings Inc announced that it has received $0.66 million in funding.	CI
31/05/13	CardioGenics Holdings Inc announced that it expects to receive $1.5 million in funding.	CI
28/02/13	CardioGenics Holdings Inc. Announces Demise of Director, Alexander D. G. Reid	CI
27/02/13	CardioGenics Holdings Inc. announced that it expects to receive $1 million in funding.	CI
17/04/12	CardioGenics Holdings Inc has Changed its Ticker to CGNH from CGNHE	CI

28/09/21	UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
09/09/21	CARDIOGENICS : ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
03/09/21	CARDIOGENICS : ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION	AQ
04/11/15	CardioGenics : Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap	MW
05/10/15	CardioGenics : Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap	MW

CardioGenics Holdings Inc Share Price

Stocks

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Valuation: CardioGenics Holdings Inc

Chart: CardioGenics Holdings Inc

Latest news : CardioGenics Holdings Inc

Press Releases: CardioGenics Holdings Inc

Quotes and Performance

Course Extremes

Managers and Directors: CardioGenics Holdings Inc

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

Current month	+9,900.00%
1 month	+9,900.00%
6 months	+9,900.00%
Current year	+9,900.00%

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.08
10 years	0		0.29

Manager	Title	Age	Since
Yahia A. Gawad CEO	Chief Executive Officer	68	26/10/2009
James A. Essex DFI	Director of Finance/CFO	78	15/06/2010
Linda J. Sterling IRC	Investor Relations Contact	65	-

Director	Title	Age	Since
Yahia A. Gawad BRD	Director/Board Member	68	05/04/2011
Julian Neil Tabatznik CHM	Chairman	76	15/06/2010
Linda J. Sterling BRD	Director/Board Member	65	15/06/2010

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARDIOGENICS HOLDINGS INC	0.00%	0.00%	+9,900.00%	0.00%	14.29K
GUARDANT HEALTH, INC.	-1.46%	-6.69%	+160.45%	+339.01%	21.1B
BIOMÉRIEUX	+0.14%	+0.34%	-42.21%	-22.18%	9.96B
10X GENOMICS, INC.	-3.54%	+7.80%	+323.64%	+11.91%	7.31B
LANTHEUS HOLDINGS, INC.	+0.01%	0.00%	+85.33%	+46.22%	6.59B
CARIS LIFE SCIENCES, INC.	-1.71%	-4.13%	-41.07%	-	6.16B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+3.22%	+6.11%	-10.58%	-7.34%	5.97B
ANDON HEALTH CO., LTD.	+1.19%	+0.81%	+83.99%	+109.77%	4.55B
DIASORIN S.P.A.	-0.64%	-1.30%	-11.45%	-18.47%	4.27B
AUTOBIO DIAGNOSTICS CO., LTD.	+3.92%	+3.82%	-18.16%	-32.66%	2.85B
Average	+0.11%	+2.59%	+1,043.00%	+47.36%	6.88B
Weighted average by Cap.	-0.47%	+1.17%	+85.20%	+121.52%

	2014	2015
Net sales	-	-
Net income	-2.68M -2.31M -2.18M -1.98M -3.72M -256M -3.78M -25.48M -9.96M -128M -10.06M -9.84M -426M	-1.92M -1.66M -1.56M -1.41M -2.66M -183M -2.7M -18.22M -7.13M -91.76M -7.19M -7.04M -305M
Net Debt	132K 114K 107K 97.61K 184K 12.64M 187K 1.26M 492K 6.33M 496K 486K 21.04M	157K 135K 127K 116K 217K 14.97M 221K 1.49M 582K 7.49M 588K 575K 24.91M